Extra-gastrointestinal stromal tumor of the pancreas: Case report and a review of the literature

Archives of Surgery

Volumn 143, Issue 3, 2008, Pages 305-308

  Showalter, Shayna L ^a,b   Lloyd, Joshua M ^a   Glassman, Deborah T ^a   Berger, Adam C ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY CARCINOMA; LAPAROSCOPIC SURGERY; LAPAROSCOPY; PANCREAS RESECTION; PANCREAS TUMOR; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SPLENECTOMY;

AGED; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LAPAROSCOPY; NEPHRECTOMY; PANCREATECTOMY; PANCREATIC NEOPLASMS; SPLENECTOMY;

EID: 41149162681     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2007.68     Document Type: Article

References (24)

1. Gold JS, DeMatteo R. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg. 2006;244(2):176-184.
2. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002;38(suppl 5):S39-S51.
3. Fletcher CD, Berman JJ, Corless C. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459-465.
4. DeMatteo RP, Lewis J, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51-58.
5. Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease. Eur J Cancer. September 2002;38(suppl 5):S37-S38.
6. Neto MR, Machica TN, Pinho RV, Yuasa LD, Bleggi-Torres LF. Gastrointestinal stromal tumor: report of two unusual cases. Virchows Arch. 2004;444(6):594-596.
7. Reşorlu B, Baltaci S, Resorlu M, Kankaya D, Savaş B. Coexistence of papillary renal cell carcinoma and gastrointestinal stromal tumor in a case. Turk J Gastroenterol. 2007;18(1):47-49.
8. Antonini C, Forgiarini O, Chiara A, et al. Stromal tumor of the ileum (GIST) at the same time as a renal carcinoma: description of a case and review of the literature. Pathologica. 1998;90(2):160-164.
9. Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol. 2007;25(7):884-896.
10. Rubin BP. Gastrointestinal stromal tumors: an update. Histopathology. 2006;48(1):83-96.
11. van der Zwan SM, Dematteo R. Gastrointestinal stromal tumor: 5 years later. Cancer. 2005;104(9):1781-1788.
12. Shinomura Y, Kinoshita K, Tsutsui S, Hirota S. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors. J Gastroenterol. 2005;40(8):775-780.
13. Popescu LM, Hinescu M, Ionescu N, Ciontea SM, Cretoiu D, Ardelean C. Interstitial cells of Cajal in pancreas. J Cell Mol Med. 2005;9(1):169-190.
14. Miettinen M, El-Rifai W, Sobin HL, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33(5):478-483.
15. Emory TS, Sobin L, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999;23(1):82-87.
16. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13(5):577-585.
17. Yamaura K, Kato K, Miyazawa M, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19(4):467-470.
18. Krska Z, Pesková M, Povýsil C, Horejs J, Sedlácková E, Kudrnová Z. GIST of pancreas. Prague Med Rep. 2005;106(2):201-208.
19. Daum O, Klecka J, Ferda J, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutation. Virchows Arch. 2005;446(4):470-472.
20. Blay JY, Bonvalot S, Casali H, et al; GIST Consensus Meeting Panelists. Consensus meeting for the management of gastrointestinal stromal tumors: report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO [published correction appears in Ann Oncol. 2005;16(6):993]. Ann Oncol. 2005;16(4):566-578.
21. McGrath PC, Neifeld JP, Lawrence WJ, Kay S, Horsley JS III, Parker GA. Gastrointestinal sarcomas: analysis of prognostic factors. Ann Surg. 1987;206(6):706-710.
22. Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 2005;315(3):971-979.
23. DeMatteo R, Owzar K, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III trial ACOSOG Z9001. Abstract presented at: the Annual Meeting of the Society of Clinical Oncology; 2007.
24. Demetri GD, van Ossterom T, Blackstein M, et al. Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients following failure of imatinib for metastatic GIST: American Society of Clinical Oncology 41st Annual Meeting Proceedings (postmeeting edition) [abstract]. J Clin Oncol. 2005;23(16)(suppl):4000.